Correspondingly, the inflammatory factors of IL-1β, TNF-α, and IL-6 were increased in the MD@SA hydrogel group (Fig. 7h and Fig. S17), offering a robust immune environment to restrict tumor regrowth. The gene discussed is IL1B; the disease is neoplasm.